6-15658674-G-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_032122.5(DTNBP1):​c.56+4140C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.34 in 152,042 control chromosomes in the GnomAD database, including 9,459 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.34 ( 9459 hom., cov: 32)

Consequence

DTNBP1
NM_032122.5 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.915

Publications

15 publications found
Variant links:
Genes affected
DTNBP1 (HGNC:17328): (dystrobrevin binding protein 1) This gene encodes a protein that may play a role in organelle biogenesis associated with melanosomes, platelet dense granules, and lysosomes. A similar protein in mouse is a component of a protein complex termed biogenesis of lysosome-related organelles complex 1 (BLOC-1), and binds to alpha- and beta-dystrobrevins, which are components of the dystrophin-associated protein complex (DPC). Mutations in this gene are associated with Hermansky-Pudlak syndrome type 7. This gene may also be associated with schizophrenia. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
DTNBP1 Gene-Disease associations (from GenCC):
  • Hermansky-Pudlak syndrome 7
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_032122.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.449 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_032122.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DTNBP1
NM_032122.5
MANE Select
c.56+4140C>T
intron
N/ANP_115498.2
DTNBP1
NM_001271668.2
c.56+4140C>T
intron
N/ANP_001258597.1A6NFV8
DTNBP1
NM_001271669.2
c.56+4140C>T
intron
N/ANP_001258598.1A0A087WYP9

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DTNBP1
ENST00000344537.10
TSL:1 MANE Select
c.56+4140C>T
intron
N/AENSP00000341680.6Q96EV8-1
DTNBP1
ENST00000622898.4
TSL:1
c.56+4140C>T
intron
N/AENSP00000481997.1A0A087WYP9
DTNBP1
ENST00000338950.9
TSL:1
c.56+4140C>T
intron
N/AENSP00000344718.5Q96EV8-2

Frequencies

GnomAD3 genomes
AF:
0.340
AC:
51639
AN:
151922
Hom.:
9446
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.455
Gnomad AMI
AF:
0.384
Gnomad AMR
AF:
0.313
Gnomad ASJ
AF:
0.342
Gnomad EAS
AF:
0.0797
Gnomad SAS
AF:
0.211
Gnomad FIN
AF:
0.214
Gnomad MID
AF:
0.328
Gnomad NFE
AF:
0.324
Gnomad OTH
AF:
0.337
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.340
AC:
51693
AN:
152042
Hom.:
9459
Cov.:
32
AF XY:
0.330
AC XY:
24502
AN XY:
74334
show subpopulations
African (AFR)
AF:
0.454
AC:
18828
AN:
41428
American (AMR)
AF:
0.312
AC:
4775
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.342
AC:
1187
AN:
3468
East Asian (EAS)
AF:
0.0801
AC:
415
AN:
5180
South Asian (SAS)
AF:
0.213
AC:
1027
AN:
4828
European-Finnish (FIN)
AF:
0.214
AC:
2254
AN:
10550
Middle Eastern (MID)
AF:
0.330
AC:
97
AN:
294
European-Non Finnish (NFE)
AF:
0.324
AC:
22053
AN:
67990
Other (OTH)
AF:
0.335
AC:
707
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1720
3441
5161
6882
8602
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
496
992
1488
1984
2480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.331
Hom.:
14278
Bravo
AF:
0.356
Asia WGS
AF:
0.167
AC:
583
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.15
DANN
Benign
0.85
PhyloP100
-0.92
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs1997679;
hg19: chr6-15658905;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.